3.83 USD
↘ 0.21 (5.20%)AT CLOSE (03:59 PM EDT)
Immuneering Corporation Class A Common Stock
IMRXNASDAQ • USD
3.86
↗ 0.03 (0.89%)
POST MARKET (AS OF 05:19 PM EDT)
Post Market
AS OF 05:19 PM EDT
3.86
↗ 0.03 (0.89%)
Market: OPEN
Immuneering Corporation Class A Common Stock (IMRX) trades at $3.86 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMRX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 5, 2026.
Open?$4.06
High?$4.09
Low?$3.81
Prev. Close?$4.04
Volume?897.5K
Avg. Volume?658.6K
VWAP?$3.92
Rel. Volume?1.36x
Bid / Ask
Bid?$3.28 × 100
Ask?$4.42 × 100
Spread?$1.14
Midpoint?$3.85
Valuation & Ratios
Market Cap?261.4M
Shares Out?64.7M
Float?56.0M
Float %?86.5%
P/E Ratio?N/A
P/B Ratio?1.37
EPS?-$0.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Themes
Employees
57
Market Cap
261.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-30
Address
245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142
Phone: 617-500-8080
CAMBRIDGE, MA 02142
Phone: 617-500-8080
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?11.55Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?27.79%Squeeze Risk
Short Interest?15.6M
Days to Cover?20.6
Free Float56.0M
Avg Daily Volume756.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?19.47Strong
Quick Ratio?19.47Strong
Cash Ratio?5.09Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.37CHEAP▾
Peers100
S&P90
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-30.0%WEAK▾
S&P6
ROA?-28.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-56991132
Enterprise Value?$220.1M
Fundamentals ratios updated end of day